Literature DB >> 25340094

Comment on: Platelet counts and mean platelet volume in association with serum magnesium in maintenance hemodialysis patients.

Azar Baradaran1.   

Abstract

Entities:  

Keywords:  Chronic kidney disease; End-stage renal disease; Hemodialysis; Magnesium; Platelets

Year:  2012        PMID: 25340094      PMCID: PMC4205985          DOI: 10.12861/jrip.2012.05

Source DB:  PubMed          Journal:  J Renal Inj Prev        ISSN: 2345-2781


× No keyword cloud information.

Implication for health policy/practice/research/medical:

Bleeding tendency is frequently seen due to disturbances in platelet adhesion and aggregation in hemodialysis. Rafieian-Kopaie and his colleague undertaken a study on 36 chronic hemodialysis patients. They found a negative association of serum magnesium with mean platelet volume. This finding needs further consideration to find clinical significance of this study. In patients with end-stage kidney disease under hemodialysis, thrombotic disorders and bleeding are major complications (1). Uremic toxins which accumulate in the blood of chronic kidney disease patients may influence platelet function, induce hemostatic disorder and mediate thrombotic disorders (1,2). Bleeding tendency of dialysis patients is regarded as hemorrhagic symptoms and prolongation of bleeding time (3,4). Bleeding tendency of dialysis is multifactorial (3,4). It is evident that abnormal platelet function is a major factor, while bleeding occurs despite a normal coagulation profile or elevated coagulation factor levels and normal platelet number (2-5). Platelet dysfunction may be as a consequence of decreased dense granule content, decreased sensitivity to platelet agonists, abnormal expression of platelet glycoproteins, defective arachidonate metabolism and depressed prostaglandin metabolism and also impaired platelet adhesiveness. Various factors responsible for platelet dysfunction such as, increased nitric oxide production, von Willebrand factor abnormalities, anemia, uremic toxins and the use of some drugs like non-steroidal anti-inflammatory drugs, aspirin (3-6). Activation of platelets and platelet degranulation can occur during the hemodialysis. A part of this activation may also occur due to contact of blood to the roller pump segment and microbubbles may play a role (4-6). Thus bleeding tendency is frequently seen due to disturbances in platelet adhesion and aggregation in hemodialysis (3-6). Rafieian-Kopaie and his colleague undertaken a study on 36 chronic hemodialysis patients (7). They found a negative association of serum magnesium with mean platelet volume. This finding needs further consideration to find clinical significance of this study.

Author’s contribution

AB is the single author of the manuscript.

Conflict of interests

The author declared no competing interests.

Ethical considerations

Ethical issues (including plagiarism, data fabrication, double publication) have been completely observed by the author.

Funding/Support

None.
  7 in total

Review 1.  Uremic bleeding: closing the circle after 30 years of controversies?

Authors:  M Noris; G Remuzzi
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

Review 2.  Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia.

Authors:  John T Daugirdas; Angelito A Bernardo
Journal:  Kidney Int       Date:  2012-05-16       Impact factor: 10.612

Review 3.  Platelet dysfunction and end-stage renal disease.

Authors:  Dinkar Kaw; Deepak Malhotra
Journal:  Semin Dial       Date:  2006 Jul-Aug       Impact factor: 3.455

Review 4.  Platelet dysfunction in renal failure.

Authors:  Paola Boccardo; Giuseppe Remuzzi; Miriam Galbusera
Journal:  Semin Thromb Hemost       Date:  2004-10       Impact factor: 4.180

5.  Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.

Authors:  Yasemin Usul Soyoral; Cengiz Demir; Huseyin Begenik; Ramazan Esen; Mehmet Emin Kucukoglu; Mehmet Naci Aldemir; Davut Demirkiran; Reha Erkoc
Journal:  Clin Appl Thromb Hemost       Date:  2012-02-12       Impact factor: 2.389

Review 6.  Hemostatic changes in patients with end stage renal disease undergoing hemodialysis.

Authors:  Danyelle Romana Alves Rios; Maria das Graças Carvalho; Bashir A Lwaleed; Ana Cristina Simões e Silva; Karina Braga Gomes Borges; Luci Maria Santana Dusse
Journal:  Clin Chim Acta       Date:  2009-11-27       Impact factor: 3.786

7.  Platelet counts and mean platelet volume in association with serum magnesium in maintenance hemodialysis patients.

Authors:  Mahmoud Rafieian-Kopaie; Hamid Nasri
Journal:  J Renal Inj Prev       Date:  2012-01-01
  7 in total
  1 in total

1.  Association of helicobacter pylori infection with serum magnesium in kidney transplant patients.

Authors:  Massoud Hafizi; Saeed Mardani; Ali Borhani; Ali Ahmadi; Parto Nasri; Hamid Nasri
Journal:  J Renal Inj Prev       Date:  2014-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.